Leishmaniasis represents a group of parasitic diseases caused by protozoan of the genus 35 Leishmania and is widely distributed in tropical and subtropical regions. Leishmaniasis is one of 36 the major tropical neglected diseases, with 1.5-2 million new cases occurring annually. Diagnosis 37 remains a challenge despite advances in parasitological, serological and molecular methods. 38 Dogs are important host for the parasite and develop both visceral and cutaneous lesions. Our 39 goal was to contribute to the diagnosis of canine cutaneous leishmaniasis (CL) and visceral 40 leishmaniasis (VL) using the recombinant cysteine proteinase B (F-CPB) from Leishmania 41 braziliensis and its N-and C-terminal domains (N-CPB and C-CPB) as antigens in an ELISA 42 assay
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pellet the cell debris. Proteins were purified under denaturing conditions from the supernatant 138 using a Ni 2+ -nitrilotriacetic acid-Sepharose matrix. Properly folded proteins were obtained by 139 extensive dialysis against buffer 2 M urea, 50 mM Tris, 5% sucrose, 10% glycerol, 0.3 M NaCl, 140 0.5 mM EDTA followed by dialysis in phosphate-buffered saline (PBS)-20% glycerol and stored 141 at -70°C until use. Protein concentration was determined by the Bradford protein assay 142 Hercules, CA), using bovine serum albumin (Sigma) as a standard. Province of Salta, NWA. The study area is included within the biogeographic "Yungas" rainforest 147 (6). The Province of Salta has been the area of Argentina with high incidence of CL, with most 148 cases originating in the Orán Department (7, 35, 36) . Moreover, L. braziliensis has been 149 acknowledged as the main causative agent for CL in this area of Argentina (7, 35) . 150 Samples stored at -20°C, were collected from 76 dogs previously diagnosed with leishmaniasis 151 by the identification of amastigotes in Giemsa-stained material obtained by touch print, scraping, 152 exudate, or aspirate obtained by injecting 0.1-0.4 ml of buffered saline solution plus penicillin-153 streptomycin followed by an aspirate of the fluid (6) . Clinical signs support the diagnosis of CL 154 (6, 37) . The entire skin surface of the dogs was carefully inspected in the search for lesions or 155 scars. Particular attention was paid to the limbs, ears, nose and scrotum, since ulcerous lesions 156 were most often found in these areas. The clinical criteria used to define "suspected leishmaniasis 
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Amastigotes observed on smears from aspirates were analyzed for the parasitological diagnosis 169 of canine VL. A puncture aspiration was aseptically performed on the dogs using 2.5 ml syringes 170 and 21-gauge needles. The aspirates were taken from enlarged lymph nodes, especially the 171 popliteal ones. When lymph nodes could not be found, the samples were taken from the bone 172 marrow or the spleen. A fraction from each sample obtained by aspiration or the scrapings were 173 stained with Giemsa and observed under an optical microscope.
174
Clinical suspicion of VL was defined by the presence of three or more of the following signs: significantly higher in CL than in non-leishmaniasis dogs (p˂ 0.0001).
272
We analyzed the accuracy of the ELISA tests to correctly classify the samples as CL. As shown 0.9562 (CI: 0.9055 to 1.007), and 0.9423 (CI: 0.8831 to 1.002) were determined for F45, F-CPB, 275 N-CPB and C-CPB, respectively. According to the traditional academic point system, all the 276 antigens showed an AUC between 0.90-1.0, which means they were excellent ligands to correctly 277 discriminate between the two groups (43).
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Interestingly, the detection of antibodies against the recombinant antigens in the ELISA 279 matrix, showed sensitivities of 0.907, 0.944 and 0.943 for F-CPB, N-CPB and C-CPB, 280 respectively, which were equal or close to those observed when a mixture of Leishmania antigen 281 (F45) was used (0.944). Moreover, F-CPB presented higher specificity and predictive positive 282 value (0.955 and 0.980) than its domains (0.909 and 0.962; and 0.913 and 0.962 for the N-CPB 283 and C-CPB, respectively) ( Table 1) . Overall, these results endorse F-CPB and its domains as human or other dogs without leishmaniasis. Interestingly, specific antibodies against all the 290 antigens tested were significantly higher in groups A, B and C, which corresponded to dogs that 291 had or could have been exposed to Leishmania parasites, with respect to those observed in 292 asymptomatic dogs (group D). Titers of specific antibodies against the recombinant proteins 293 agreed with those observed against the parasite lysate (Fig 4) . We then analyzed the efficiency of the different antigens in the diagnosis of VL in dogs. As 297 shown in Fig 5, significant differences in reactivity against F-CPB and its domains were observed 298 among dogs suffering from VL or not.
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The ELISA containing F-CPB exhibited the best performance compared to the other antigens 300 tested (AUC: 0.879, 0.789 and 0.723, for F-CPB, N-CPB and C-CPB respectively). These results 301 mean that F-CPB as a coating antigen in an ELISA assay is a good candidate for the diagnosis of 302 VL in dogs (Fig 6) . In addition, we observed higher sensitivity (Se) (93.3%) and specificity (Sp)
303
(92.30 %) for F-CPB compared to the N-(Se: 73.3 % and Sp 76.9%) and C-terminal domains (Se: 304 66.7 and Sp: 88.5 %) ( Table 2) .
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The CPB amino acid sequence is highly conserved among Leishmania species 307 In order to further analyze whether CPB could be a promising antigen for the diagnosis of Fig 2, 5 and Tables 1, 2) . Moreover, the high 334 sensitivity of the CPB from L. braziliensis in the diagnosis of VL (93.3%) could be explained 335 considering the higher stimulation of the immune system in the visceral form compared to a 336 localized cutaneous presentation (Se: 90.7). In that regard, several reports (50) (51) (52) have shown the 337 importance of the CPB from L. infantum and L. (L.) chagasi as targets of the humoral and cellular 338 immune response and their potential use for the diagnosis of VL in humans and dogs. 339 Bearing in mind that the species that cause CL and VL disease are generally different, the 340 ability of the CPB from L. braziliensis to detect the infection caused by different Leishmania 341 strains highlights its value as a candidate for the universal diagnosis of leishmaniasis. This is also 
